RU2015137094A3 - - Google Patents

Download PDF

Info

Publication number
RU2015137094A3
RU2015137094A3 RU2015137094A RU2015137094A RU2015137094A3 RU 2015137094 A3 RU2015137094 A3 RU 2015137094A3 RU 2015137094 A RU2015137094 A RU 2015137094A RU 2015137094 A RU2015137094 A RU 2015137094A RU 2015137094 A3 RU2015137094 A3 RU 2015137094A3
Authority
RU
Russia
Application number
RU2015137094A
Other languages
Russian (ru)
Other versions
RU2015137094A (ru
RU2677229C2 (ru
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/013992 external-priority patent/WO2014120995A2/en
Publication of RU2015137094A publication Critical patent/RU2015137094A/ru
Publication of RU2015137094A3 publication Critical patent/RU2015137094A3/ru
Application granted granted Critical
Publication of RU2677229C2 publication Critical patent/RU2677229C2/ru

Links

RU2015137094A 2013-02-01 2014-01-31 Соединения амина, имеющие противовоспалительную, противогрибковую, противопаразитарную и противораковую активность RU2677229C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361759512P 2013-02-01 2013-02-01
US61/759,512 2013-02-01
PCT/US2014/013992 WO2014120995A2 (en) 2013-02-01 2014-01-31 Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2019100054A Division RU2721418C2 (ru) 2013-02-01 2014-01-31 Соединения амина, имеющие противовоспалительную, противогрибковую, противопаразитарную и противораковую активность

Publications (3)

Publication Number Publication Date
RU2015137094A RU2015137094A (ru) 2017-03-09
RU2015137094A3 true RU2015137094A3 (enExample) 2018-01-31
RU2677229C2 RU2677229C2 (ru) 2019-01-16

Family

ID=51263115

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2015137094A RU2677229C2 (ru) 2013-02-01 2014-01-31 Соединения амина, имеющие противовоспалительную, противогрибковую, противопаразитарную и противораковую активность
RU2019100054A RU2721418C2 (ru) 2013-02-01 2014-01-31 Соединения амина, имеющие противовоспалительную, противогрибковую, противопаразитарную и противораковую активность

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2019100054A RU2721418C2 (ru) 2013-02-01 2014-01-31 Соединения амина, имеющие противовоспалительную, противогрибковую, противопаразитарную и противораковую активность

Country Status (17)

Country Link
US (5) US10030015B2 (enExample)
EP (2) EP3632426A1 (enExample)
JP (2) JP6463276B2 (enExample)
KR (2) KR20210007046A (enExample)
CN (2) CN104968200B (enExample)
AU (2) AU2014212242B2 (enExample)
BR (2) BR122021012629B1 (enExample)
CA (3) CA3102531A1 (enExample)
DK (1) DK2950649T3 (enExample)
ES (1) ES2790675T3 (enExample)
IL (2) IL240205B (enExample)
MX (5) MX369611B (enExample)
NZ (1) NZ709885A (enExample)
PL (1) PL2950649T3 (enExample)
RU (2) RU2677229C2 (enExample)
WO (1) WO2014120995A2 (enExample)
ZA (1) ZA201504954B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122021012629B1 (pt) * 2013-02-01 2022-06-07 Wellstat Therapeutics Corporation Compostos de amina, composição compreendendo os referidos compostos e usos dos mesmos
JP6247992B2 (ja) * 2014-04-17 2017-12-13 株式会社ダイセル ハロゲン化合物の製造方法
US10231958B2 (en) 2014-10-24 2019-03-19 The Board Of Regents Of The University Of Texas System Methods and compositions for enhancing chemotherapy
SG11201606876RA (en) 2015-03-04 2016-10-28 Gilead Sciences Inc Toll like receptor modulator compounds
SI3507276T1 (sl) 2016-09-02 2022-01-31 Gilead Sciences, Inc. Spojine modulatorja toličnih receptorjev
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
WO2018122746A1 (en) 2016-12-28 2018-07-05 Minoryx Therapeutics S.L. Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions associated with the alteration of the activity of beta galactosidase
US12539297B2 (en) 2017-02-07 2026-02-03 Oncocross Co., Ltd. Composition for inhibiting cancer metastasis and treating cancer
WO2018147612A1 (ko) * 2017-02-07 2018-08-16 주식회사 온코크로스 암의 전이 억제 및 치료용 조성물
EP3596043B1 (en) * 2017-03-15 2025-12-03 Lunella Biotech, Inc. Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
JP6635999B2 (ja) * 2017-10-13 2020-01-29 株式会社ダイセル カリウム塩の製造方法、及びカリウム塩
CN108084089B (zh) * 2017-12-08 2020-10-23 华南农业大学 一种防治白色念珠菌的2-烷基胺喹啉类化合物及其制备方法与应用
CN108892634B (zh) * 2018-06-19 2021-04-23 浙江工业大学 一种吲哚甲基苯胺类化合物及其应用
CN108997172B (zh) * 2018-08-08 2020-12-15 中国人民解放军总医院 抗肿瘤化合物
CN113286785A (zh) * 2019-01-04 2021-08-20 贝尔布鲁克实验室有限责任公司 作为治疗剂的cGAS活性的抑制剂
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
KR102286897B1 (ko) 2019-06-25 2021-08-09 (주)앰틱스바이오 신규한 아미노알칸산에 바이페닐기를 도입한 유도체 화합물 및 이를 포함하는 항진균성 약학적 조성물
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
GB201909659D0 (en) * 2019-07-04 2019-08-21 Aberystwyth Univ Anti-infective compounds
CN110804013B (zh) * 2019-10-09 2024-04-05 南京工业大学 一种邻位二胺类化合物的合成方法
AU2021347360A1 (en) * 2020-09-25 2023-05-25 Escient Pharmaceuticals, Inc. Modulators of mas-related g-protein receptor x2 and related products and methods
BR112023011284A2 (pt) 2020-12-09 2024-02-06 Wellstat Therapeutics Corp Composto de imidazoquinolina com atividade anti-inflamatória, antifúngica, antiparasítica e antineoplásica
TW202320766A (zh) * 2021-09-29 2023-06-01 大陸商上海海和藥物研究開發股份有限公司 一類具有吡啶并六員環結構的ｓｏｓ１抑制劑
EP4580618A2 (en) * 2022-08-30 2025-07-09 Pannex Therapeutics Inc. Pannexin-1 modulators and methods of treating disorders in which pannexin-1 is implicated
WO2025069039A1 (en) * 2023-09-28 2025-04-03 Rajaram Samant An in situ process for the preparation of primary amine compounds
WO2025143877A1 (ko) * 2023-12-28 2025-07-03 (주)앰틱스바이오 아미노 니코틴아마이드 구조를 포함하는 유도체 화합물 및 이를 포함하는 항진균성 약학적 조성물

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4320294Y1 (enExample) 1964-10-31 1968-08-26
CH492395A (de) * 1966-04-26 1970-06-30 Sandoz Ag Mittel zur Bekämpfung von Pflanzenschädlingen und Verwendung des Mittels
GB1496371A (en) * 1975-08-18 1977-12-30 Serdex 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof
GB1582407A (en) * 1977-06-07 1981-01-07 Worcester Controls Uk Ltd Annular seals
JPS53103484A (en) * 1977-02-21 1978-09-08 Takeda Chem Ind Ltd Quinazoline derivatives, process for their preparation and nsecticedes and fungicides
JPS542325A (en) 1977-06-07 1979-01-09 Sankyo Co Ltd Agricultural and horticultural pesticide
JPS5576803A (en) * 1978-12-06 1980-06-10 Sankyo Co Ltd Agent for controlling noxious life
GB2068732B (en) * 1980-02-08 1983-06-02 Sandoz Ltd Ectoparasites compounds
US4331667A (en) * 1980-02-08 1982-05-25 Sandoz Ltd. Quinazolines for controlling ectoparasites
GB2135887A (en) 1983-03-08 1984-09-12 Sandoz Ltd 4-Alkylamino-quinazolines used as insecticides
GB8306360D0 (en) 1983-03-08 1983-04-13 Sandoz Ltd Quinazolines
ZA848968B (en) 1983-11-18 1986-06-25 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
CA1271477A (en) * 1983-11-18 1990-07-10 John F. Gerster 1h-imidazo[4,5-c]quinolin-4-amines
US5114939A (en) * 1988-01-29 1992-05-19 Dowelanco Substituted quinolines and cinnolines as fungicides
US5294622A (en) * 1988-01-29 1994-03-15 Dowelanco Substituted quinolines and cinnolines
IL89026A (en) * 1988-01-29 1993-02-21 Lilly Co Eli Substituted quinolines and cinnolines, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
US5278173A (en) * 1988-06-30 1994-01-11 Davis Michael H Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo
JPH03505579A (ja) * 1988-06-30 1991-12-05 デービス，マイクル，エイチ ヒト免疫不全ウイルス（ｈｉｖ）のインビボにおける活性の阻害方法
US5141941A (en) 1988-11-21 1992-08-25 Ube Industries, Ltd. Aralkylamine derivatives, and fungicides containing the same
US5389640A (en) 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
DE69229114T2 (de) * 1991-03-01 1999-11-04 Minnesota Mining And Mfg. Co., Saint Paul 1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine
NZ243082A (en) * 1991-06-28 1995-02-24 Ici Plc 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
AU661533B2 (en) 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
GB9510757D0 (en) * 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
GB9508538D0 (en) 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
US6046206A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
GB9612829D0 (en) 1996-06-19 1996-08-21 Univ London Potassium channel blockers
DE19647317A1 (de) 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituierte Stickstoff-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
EP0982300A3 (en) * 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
SE0102858D0 (sv) * 2001-08-27 2001-08-27 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
HUP0105407A3 (en) 2001-12-21 2004-04-28 Sanofi Aventis Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0105406A3 (en) 2001-12-21 2003-12-29 Sanofi Aventis Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
EP2573079A3 (en) 2002-08-23 2015-03-11 Novartis AG Benzimidazole quinolinones and uses thereof
HUP0203976A3 (en) 2002-11-15 2004-08-30 Sanofi Aventis Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
TWI328009B (en) 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
JP4823914B2 (ja) 2003-11-07 2011-11-24 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Ｆｇｆｒ３の阻害および多発性骨髄腫の治療
EP1718306A2 (en) 2004-02-20 2006-11-08 Chiron Corporation Modulation of inflammatory and metastatic processes
US20060074105A1 (en) * 2004-09-20 2006-04-06 Serenex, Inc. Substituted quinoline and quinazoline inhibitors of quinone reductase 2
EP1844023A1 (en) 2004-12-31 2007-10-17 Sk Chemicals Co., Ltd. Quinazoline derivatives for the treatment and prevention of diabetes and obesity
EP1945222B1 (en) * 2005-11-02 2012-12-26 Bayer Pharma Aktiengesellschaft Pyrrolo[2,1-f] [1,2,4]-triazin-4-ylamines as igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
ES2429170T3 (es) 2005-11-04 2013-11-13 3M Innovative Properties Company 1H-Imidazoquinolinas sustituidas con hidroxilo y alcoxilo y métodos
US7928111B2 (en) 2007-06-08 2011-04-19 Senomyx, Inc. Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
ES2523169T3 (es) 2008-01-25 2014-11-21 High Point Pharmaceuticals, Llc Compuestos tricíclicos como moduladores de la síntesis de TNF y como inhibidores de PDE4
JP5599783B2 (ja) 2008-05-30 2014-10-01 アムジエン・インコーポレーテツド Ｐｉ３キナーゼの阻害薬
JP2012502067A (ja) 2008-09-10 2012-01-26 カリプシス・インコーポレーテッド 疾患の治療のためのヒスタミン受容体の複素環阻害剤
WO2010074783A1 (en) 2008-12-23 2010-07-01 The Trustees Of Columbia University In The City Of New York Phosphodiesterase inhibitors and uses thereof
JP2012513464A (ja) * 2008-12-23 2012-06-14 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク ホスホジエステラーゼ阻害剤及びその使用
KR101699991B1 (ko) 2009-02-11 2017-01-26 메르크 파텐트 게엠베하 신규의 아미노 아자헤테로시클릭 카르복사미드
CN102625799A (zh) 2009-06-25 2012-08-01 安姆根有限公司 杂环化合物及其用途
PH12012500097A1 (en) 2009-07-21 2011-01-27 Shanghai Inst Organic Chem Potent small molecule inhibitors of autophagy, and methods of use thereof
JP2011026251A (ja) 2009-07-27 2011-02-10 Kowa Co ２−アリールアミノキノリン化合物及びこれを有効成分として含有するエリスロポエチン産生促進剤
KR101467996B1 (ko) * 2010-04-30 2014-12-11 전북대학교산학협력단 에이디피-리보실 사이클라제 활성을 저해하는 퀴나졸린 유도체
WO2012079079A1 (en) * 2010-12-10 2012-06-14 President And Fellows Of Harvard College Production of induced pluripotent stem cells
US20140050696A1 (en) 2011-04-29 2014-02-20 Ravi K. Amaravadi Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
BR122021012629B1 (pt) 2013-02-01 2022-06-07 Wellstat Therapeutics Corporation Compostos de amina, composição compreendendo os referidos compostos e usos dos mesmos

Similar Documents

Publication Publication Date Title
BR112021000792B8 (enExample)
AT524834A2 (enExample)
AT521543A3 (enExample)
AT524961A5 (enExample)
AT524266A2 (enExample)
BR102019026286B1 (pt) Método e aparelho para o avanço de produtos a serem moldados
BR102019025884B1 (pt) Sistema de segurança aprimorado para máquinas de operação de autopropulsão
BR102019023514B1 (pt) Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna
BR112021001374B1 (pt) Composição farmacêutica para o tratamento da hipertensão e seu uso
BR112021001128B1 (pt) Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit
BR112020023795B1 (pt) Composição de recheio para um produto de chocolate à base de gordura, e seus métodos de produção
BR112021000922B1 (pt) Tela de filtro, e, método para purificar água de alimentação
BR112020026077B1 (pt) Recipiente com estrutura encaixável
BR112020023832B1 (pt) Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral
BR112020024987B1 (pt) Método, montagem e sistema para prover uma estrutura de base, método industrial, e, braço mecânico
BR112020023823B1 (pt) Distribuidor
BR112020022482B1 (pt) Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico
BR112020022658B1 (pt) Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido
BR112020022516B1 (pt) Processo para degomagem enzimática de óleo
BR112020021042B1 (pt) Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas
BR112020020812B1 (pt) Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado
BR102019000241B1 (pt) Veículo modular, configurável, sobre plataforma de chassis comum, e métodos e sistemas associados
BR102018073077B1 (pt) Processo de extração de gelatina de resíduos de couro curtido ao cromo wet blue
BR112020022381B1 (pt) Terminal para desempenhar um procedimento de acesso aleatório baseado em contenção para solicitação de informações de sistema e método relacionado
BR112020020233B1 (pt) Método e aparelho para envio de transmissão de difusão de sincronização